Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy

Pancreatic cancer is an aggressive disease and the fourth most lethal cancer in developed countries. Despite all progress in medicine and in understanding the molecular mechanisms of carcinogenesis, pancreatic cancer still has a poor prognosis, the median survival after diagnosis being around 3 to 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Passadouro, Marta, Faneca, Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881540/
https://www.ncbi.nlm.nih.gov/pubmed/27187371
http://dx.doi.org/10.3390/ijms17050718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881540/
https://www.ncbi.nlm.nih.gov/pubmed/27187371
http://dx.doi.org/10.3390/ijms17050718

Ejemplares similares